Smith & Nephew plc
SNN Real Time Price USDRecent trades of SNN by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in SNN holdings by institutional investors
Quarterly net insider trading by SNN's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$340,000 Jan 20, 2026 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Trade (domestic/foreign) Defense
-
$350,000 Oct 20, 2025 Issue: Trade (domestic/foreign) Defense Medicare/Medicaid Taxation/Internal Revenue Code Environment/Superfund
-
$370,000 Jul 21, 2025 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Defense Environment/Superfund Trade (domestic/foreign)
-
$430,000 Apr 21, 2025 Issue: Defense Medicare/Medicaid Taxation/Internal Revenue Code Environment/Superfund Trade (domestic/foreign)
-
$430,000 Jan 15, 2025 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Environment/Superfund Trade (domestic/foreign)
-
$440,000 Oct 21, 2024 Issue: Trade (domestic/foreign) Environment/Superfund Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
-
$390,000 Jul 18, 2024 Issue: Budget/Appropriations Environment/Superfund Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
-
$50,000 Jan 22, 2024 Issue: Medicare/Medicaid Health Issues
-
$410,000 Oct 18, 2023 Issue: Environment/Superfund Health Issues Taxation/Internal Revenue Code Medicare/Medicaid
SNN Estimated quarterly lobbying spending
SNN Revenue by Segment or Geography
New SNN patent grants
-
Patent Title: Flexible deformable suture anchor Apr. 02, 2024
-
Patent Title: Medical dressing Sep. 26, 2023
-
Patent Title: Portable negative pressure apparatus May. 09, 2023
-
Patent Title: Electrosurgical wand distal tip Mar. 21, 2023
-
Patent Title: Portable negative pressure apparatus Feb. 07, 2023
-
Patent Title: Medical dressing Oct. 04, 2022
-
Patent Title: Display screen with surgical controller graphical user interface Jul. 12, 2022
-
Patent Title: Display screen with surgical controller graphical user interface Jul. 12, 2022
-
Patent Title: Display screen with surgical controller graphical user interface Jul. 12, 2022
-
Patent Title: Combined controller Apr. 05, 2022
-
Patent Title: Foot pedal assembly Apr. 05, 2022
-
Patent Title: Wound dressing and method of treatment Apr. 27, 2021
-
Patent Title: Wound dressing Mar. 30, 2021
-
Patent Title: Medical dressing Oct. 27, 2020
-
Patent Title: Medical dressing Oct. 13, 2020
-
Patent Title: Plasma surgical device distal tip Aug. 25, 2020
-
Patent Title: Apparatuses and methods for negative pressure wound therapy Jul. 28, 2020
-
Patent Title: Device for applying negative pressure to a wound Jul. 28, 2020
-
Patent Title: Canister for collecting wound exudate Dec. 17, 2019
-
Patent Title: Flexible port used to connect a wound dressing to a source of negative pressure Nov. 12, 2019
-
Patent Title: Medical dressing Oct. 15, 2019
-
Patent Title: Medical dressing Oct. 15, 2019
-
Patent Title: Bag Jul. 16, 2019
-
Patent Title: Display screen or portion thereof with a graphical user interface for a therapy device Dec. 11, 2018
-
Patent Title: Package Nov. 20, 2018
-
Patent Title: Medical dressing Oct. 30, 2018
-
Patent Title: Medical dressing Jun. 19, 2018
-
Patent Title: Wound therapy packaging with surface ornamentation May. 29, 2018
-
Patent Title: Attachment for securing a therapy device May. 22, 2018
-
Patent Title: Method and apparatus for bridging from a dressing in negative pressure wound therapy May. 08, 2018
-
Patent Title: Device for applying negative pressure to a wound Apr. 17, 2018
-
Patent Title: Therapy unit assembly Apr. 17, 2018
-
Patent Title: Medical dressing Apr. 10, 2018
-
Patent Title: Therapy unit assembly Mar. 27, 2018
-
Patent Title: Canister for collecting wound exudate Mar. 20, 2018
-
Patent Title: Surface ornamentation for wound therapy packaging Jan. 02, 2018
-
Patent Title: Medical dressing Dec. 26, 2017
-
Patent Title: Flexible port used to connect a wound dressing to a source of negative pressure Dec. 26, 2017
-
Patent Title: Flexible port used to connect a wound dressing to a source of negative pressure Dec. 26, 2017
-
Patent Title: Suction adapter Nov. 28, 2017
-
Patent Title: Canister for collecting wound exudate Nov. 14, 2017
-
Patent Title: Packaging for a wound therapy system Sep. 26, 2017
-
Patent Title: Mount apparatus for portable negative pressure apparatus Sep. 05, 2017
-
Patent Title: Medical dressing Jan. 31, 2017
-
Patent Title: Hindfoot nail Jul. 26, 2016
-
Patent Title: Hip distraction Jul. 12, 2016
-
Patent Title: Hip distraction Jun. 21, 2016
-
Patent Title: Hindfoot nail May. 24, 2016
-
Patent Title: Medical dressing Jan. 26, 2016
-
Patent Title: Hindfoot nail Sep. 17, 2013
Federal grants, loans, and purchases
- $360,000 2025-10-01 00:00:00 Agency: Department of Veterans Affairs
- $223,518 2025-09-09 00:00:00 Agency: Department of Veterans Affairs
- $21,442 2025-09-04 00:00:00 Agency: Department of Veterans Affairs
- $45,000 2025-08-27 00:00:00 Agency: Department of Veterans Affairs
- $12,538 2025-08-12 00:00:00 Agency: Department of Veterans Affairs
- $0 2025-07-16 00:00:00 Agency: Department of Veterans Affairs
- $33,561 2025-06-17 00:00:00 Agency: Department of Defense
- $120,000 2025-05-28 00:00:00 Agency: Department of Veterans Affairs
- $288,000 2024-10-01 00:00:00 Agency: Department of Veterans Affairs
- $0 2024-05-23 00:00:00 Agency: Department of Veterans Affairs
- $37,500 2024-04-22 00:00:00 Agency: Department of Veterans Affairs
- $35,204 2024-02-16 00:00:00 Agency: Department of Veterans Affairs
- $199,950 2024-02-09 00:00:00 Agency: Department of Veterans Affairs
- $12,336 2024-01-26 00:00:00 Agency: Department of Veterans Affairs
- $25,542 2023-12-22 00:00:00 Agency: Department of Veterans Affairs
- $25,179 2023-12-21 00:00:00 Agency: Department of Veterans Affairs
- $14,478 2023-12-12 00:00:00 Agency: Department of Veterans Affairs
- $18,431 2023-11-17 00:00:00 Agency: Department of Veterans Affairs
- $15,050 2023-11-07 00:00:00 Agency: Department of Veterans Affairs
- $10,646 2023-10-30 00:00:00 Agency: Department of Veterans Affairs
- $47,059 2023-10-26 00:00:00 Agency: Department of Veterans Affairs
- $23,102 2023-10-12 00:00:00 Agency: Department of Veterans Affairs
- $22,957 2023-10-03 00:00:00 Agency: Department of Veterans Affairs
- $432,000 2023-10-01 00:00:00 Agency: Department of Veterans Affairs
- $15,624 2023-09-27 00:00:00 Agency: Department of Veterans Affairs
- $24,925 2023-09-25 00:00:00 Agency: Department of Veterans Affairs
- $25,068 2023-09-19 00:00:00 Agency: Department of Veterans Affairs
- $13,001 2023-09-18 00:00:00 Agency: Department of Veterans Affairs
- $49,348 2023-09-15 00:00:00 Agency: Department of Veterans Affairs
- $23,234 2023-09-14 00:00:00 Agency: Department of Veterans Affairs
- $22,262 2023-09-13 00:00:00 Agency: Department of Veterans Affairs
- $18,000 2023-09-08 00:00:00 Agency: Department of Veterans Affairs
- $0 2023-09-08 00:00:00 Agency: Department of Veterans Affairs
- $14,184 2023-09-08 00:00:00 Agency: Department of Veterans Affairs
- $10,343 2023-09-07 00:00:00 Agency: Department of Veterans Affairs
- $11,137 2023-09-07 00:00:00 Agency: Department of Veterans Affairs
- $22,075 2023-08-30 00:00:00 Agency: Department of Veterans Affairs
- $25,224 2023-08-30 00:00:00 Agency: Department of Veterans Affairs
- $36,227 2023-08-25 00:00:00 Agency: Department of Veterans Affairs
- $16,188 2023-08-15 00:00:00 Agency: Department of Veterans Affairs
- $12,975 2023-08-13 00:00:00 Agency: Department of Veterans Affairs
- $49,850 2023-08-02 00:00:00 Agency: Department of Veterans Affairs
- $32,539 2023-07-14 00:00:00 Agency: Department of Veterans Affairs
- $26,065 2023-07-13 00:00:00 Agency: Department of Veterans Affairs
- $35,173 2023-07-12 00:00:00 Agency: Department of Veterans Affairs
- $34,283 2023-07-12 00:00:00 Agency: Department of Veterans Affairs
- $22,275 2023-07-06 00:00:00 Agency: Department of Veterans Affairs
- $16,069 2023-06-20 00:00:00 Agency: Department of Veterans Affairs
Estimated quarterly amount awarded to SNN from public contracts
Recent insights relating to SNN
Recent picks made for SNN stock on CNBC
ETFs with the largest estimated holdings in SNN
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $SNN stock a Buy, Sell, or Hold?
- What is the price target for $SNN stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $SNN stock?
- Who owns the most shares of $SNN stock?
- What funds own $SNN stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SNN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.